19 related articles for article (PubMed ID: 2673925)
1. Saccharomyces cerevisiae can release hepatitis B virus surface antigen (HBsAg) particles into the medium by its secretory apparatus.
Kuroda S; Miyazaki T; Otaka S; Fujisawa Y
Appl Microbiol Biotechnol; 1993 Nov; 40(2-3):333-40. PubMed ID: 7764388
[TBL] [Abstract][Full Text] [Related]
2. Synthesis in yeast of hepatitis B virus surface antigen modified P31 particles by gene modification.
Itoh Y; Fujisawa Y
Biochem Biophys Res Commun; 1986 Dec; 141(3):942-8. PubMed ID: 3028394
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus envelope L protein particles. Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization.
Kuroda S; Otaka S; Miyazaki T; Nakao M; Fujisawa Y
J Biol Chem; 1992 Jan; 267(3):1953-61. PubMed ID: 1370486
[TBL] [Abstract][Full Text] [Related]
4. [Expression of the HBsAg gene of the hepatitis B virus under the control of the promoter region of gene PH05 in yeast cells].
Granovskiĭ NN; Zhdanov VM; Smirnov MN
Vopr Virusol; 1985; 30(5):558-61. PubMed ID: 3907141
[TBL] [Abstract][Full Text] [Related]
5. Expression of hepatitis B virus surface antigen P31 gene in Escherichia coli.
Fujisawa Y; Ito Y; Ikeyama S; Kikuchi M
Gene; 1985; 40(1):23-9. PubMed ID: 3005125
[TBL] [Abstract][Full Text] [Related]
6. The N-terminal (pre-S2) domain of a hepatitis B virus surface glycoprotein is translocated across membranes by downstream signal sequences.
Eble BE; Lingappa VR; Ganem D
J Virol; 1990 Mar; 64(3):1414-9. PubMed ID: 2304150
[TBL] [Abstract][Full Text] [Related]
7. Efficient expression of genetically engineered hepatitis B virus surface antigen P31 proteins in yeast.
Kuroda S; Itoh Y; Miyazaki T; Otaka-Imai S; Fujisawa Y
Gene; 1989 May; 78(2):297-308. PubMed ID: 2673925
[TBL] [Abstract][Full Text] [Related]
8. Translocation of proteins across the membrane of the endoplasmic reticulum: a place for Saccharomyces cerevisiae.
Larriba G
Yeast; 1993 May; 9(5):441-63. PubMed ID: 8391742
[No Abstract] [Full Text] [Related]
9. [Production of hepatitis B vaccine by applying genetic engineering technology].
Miyanohara A; Matsubara K
Nihon Rinsho; 1983 May; 41(5):1120-34. PubMed ID: 6355559
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
